Recurrent Breast Cancer Terminated Phase 2 Trials for Vorinostat (DB02546)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00132002Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast CancerTreatment